Stocks / Biotech
AMGNBiotech
Amgen Inc
$379.341d +1.1%5d -1.0%settled close · 2026-09-17
Mkt cap $188B (3/25)β 0.5352w $271–444Shares 539.1MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 1983Emp. 31,500HQ Thousand Oaks, CAamgen.com
The tape, with the calls on it
Who said what, and what AMGN did next
Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.
bullish
bearish
both sides
Who’s talkingIdea Scout · free
Who’s talking about AMGN
1 longlatest 2026-08-04
| Date | Voice | Stance | Venue | Thesis |
|---|---|---|---|---|
| 2026-08-04 | Rob Investment CommitteeCo-Founder & CEO, NewEdge Wealth | Bullish | CNBC Halftime Final Trades | Amgen is entering the GLP-1 space as a potential upside catalyst, has one of the best pipelines in biotech… |
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 2 Nov 2026 after the close
Confirmed date · consensus EPS 5.90. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where AMGN’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 19 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-17 | ||||||
| 2026-09-10 | ||||||
| 2026-09-08 | ||||||
| 2026-08-20 | ||||||
| 2026-08-19 | ||||||
| 2026-08-05 | ||||||
| 2026-07-17 | ||||||
| 2026-05-14 | ||||||
| 2026-05-05 | ||||||
| 2026-05-01 | ||||||
| 2026-04-30 | ||||||
| 2026-04-29 | ||||||
| 2026-04-28 | ||||||
| 2026-04-27 | ||||||
| 2026-04-24 | ||||||
| 2026-04-23 | ||||||
| 2026-04-22 | ||||||
| 2026-04-21 | ||||||
| 2026-04-20 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
AMGN is in this morning’s Brief.
Get The Brief — $20/mo →